Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
International Stem Cell Corporation
ISCO | US
0.18
USD0
0%
ISCO | US
About International Stem Cell Corporation
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
0.18
Open
0.16
High
0.18
Low
0.16
View Less
ISCO | US
Risk
86.1
Sharpe
0.42
Luna's Score
55/100
Recommendation
Hold
Luna says (ISCO | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
67.5%1 month
86.1%3 months
170.0%6 months
152.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
166.00
Ent. to rev.
0.41
PEG
-
Other Fundamentals
EBITDA
-356.00K
MarketCap
1.41M
MarketCap(USD)
1.41M
Div. yield
-
Op. margin
6.39
Erngs. growth
-74.20
Rev. growth
26.60
Ret. on equity
-185.37
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.04
Range1M
0.04
Range3M
0.06
Volumes: Market Activity
Rel. volume
7.30
Price X volume
5.11K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 166.00 | 0.53 | Expensive |
| Ent. to Revenue | 0.41 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 169.99 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 1.41M | 3.66B | Emerging |
